Clinical Trials Directory

Trials / Unknown

UnknownNCT02018913

Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Accepted

Summary

Alzheimer's disease (AD) and vascular dementia (VaD) are the most common forms of dementia. Yet, the cause of these diseases is still unknown. A potentially important initiating factor is a disrupted blood-brain barrier. This can initiate cerebral microangiopathy, which has frequently been associated with VaD. Nevertheless, also in most AD patients a substantial increase of vascular damage has been observed. The present study investigates the correlation between blood-brain-barrier breakdown and cognitive decline in AD and VaD. An innovative dynamic contrast-enhanced MRI scan that has recently been developed and tested at our institute, will be used to measure blood-brain barrier permeability. Objective: We will investigate the relationship between this permeability measure and (i) cognitive performance and (ii) the status of MRI visible cerebrovascular pathology (i.e. white matter hyperintensities, lacunar infarctions, microbleeds) in the most common forms of dementia.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2013-12-23
Last updated
2013-12-23

Source: ClinicalTrials.gov record NCT02018913. Inclusion in this directory is not an endorsement.